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P-0077 hTERT CIRCULATING DNA AS AN INDICATOR FOR GASTRIC
AND ESOPHAGEAL CANCERS IN ARDABIL, IRAN
Saied Hosseini-Asl, Zohreh Shirzad, Homa Akhavan, Abbas Yazdanbod, Farhad
Pourfarzi, Mohammad Mazani, Reza Didevar
Ardabil University of Medical Sciences, Ardabil, Iran
Background: In Iran, Gastric Cancer (GC) is the most common cancer in the men and
has been detected as the third among woman. Ardabil province, in northwestern Iran,
has the highest rate of GC in this country. Esophageal Cancer (EC) is a relatively rare
form of cancer, but some world areas have a markedly higher incidence than others:
Belgium, China, Iran, Iceland, India, Japan, the United Kingdom, appear to have
a higher incidence, as well as the region around the Caspian Sea. The American Cancer
Society estimates that during 2007, approximately 15,560 new esophageal cancer cases
will be diagnosed in the United States. Esophageal cancer is the 6thmost common cause
of cancer death in the world. Among last years, circulating nucleic acids on serum and
plasma have been detected as an indicator in some cancers. In the present investigation,
detecting the human TElomerase Reverse Transcriptase (hTERT) DNA as catalytic
subunit of telomerase on serum of cancer affected patients compared to control group
has been studied.
Methods: DNA extraction was carried out on serum samples obtained from 100
primary GC affected patients, 100 primary EC affected patients and 100 participants
with any detected cancer affecting persons in their 1st to 3rd degree of relatives as
control group for each type of cancer. Quantitation detecting the hTERT DNA was
performed by the TaqMan assay on Real time PCR system by using appropriate serial
dilutions of genomic DNA to create standard curve.
Results: Qualitative findings showed hTERT DNA presentation in 45.4%, 68.5%, and
23.9% of GC group, EC group, and controls, respectively. Those tend to significant
associations between hTERT DNA in the serum and GC and EC in our province.
Quantitative amounts of detected hTERT DNA were associated with gastric and
esophageal carcinomas and the tumors pathologic indicators as well.
Conclusion: Finding prognostic factors by non-invasive assays could help us to
manage the therapeutic and diagnostic procedures, especially for cancers with low
survival such as GC and EC. Also, associations found between hTERT in the serum and
pathologic data indicate on the important role of telomerase activation in gastric and
esophageal tumorogenesis.
P-0078 HELICOBACTER PYLORI DOES NOT AFFECT THE
EXPRESSION OF MICROSATELLITE INSTABILITY AND P53 IN EARLY
GASTRIC CANCER TREATED BY ENDOSCOPIC SUBMUCOSAL
DISSECTION
Seokreyol Choi1, Joo Young Cho2, Changheon Yang3
1Dong-A University, Busan, Republic of Korea, 2Soonchunhyang University,
Seoul, Republic of Korea, 3Dongguk University, Gyoungju, Republic of Korea
Background: To investigate the relationship between Helicobacter pylori (H pylori)
infection, microsatellite instability(MSI) and the expressions of the p53 in gastric
adenocarcinoma and to elucidate the mechanism of gastric carcinogenesis relating to H
pylori infection in early gastric cancers (EGCs) treated by endoscopic submucosal
dissection (ESD).
Methods: Since May 2005 through September 2010, patients with EGC who were
candidate of endoscopic submucosal dissection were enrolled. MSI loci were studied by
PCR-SSCP-CE using the markers BAT-26, D17S261, D3S1283, D2S123, and D3S1611.
MSI was defined as the peak shift in the DNA of the gastric tissue compared with that of
the peripheral blood samples. Based on the number of mutated MSI markers,
specimens were characterized as MSI if they manifested instability at least one marker
and microsatellite stable(MSS) if they showed no instability at any marker. H.pylori
infection was detected by urea breath test and rapid urease test. p53 expression was
detected by tissue immunohistochemical staining.
Results: 140 patients were enrolled. Male were 89 and female were 51. Average age was
62.9. Presence ofH.pylori was noted in 71 patients (50.7%). Presence between MSS and
MSI was expressed in 127(90.7%) and 13(9.3%). Presence of p53 was noted in
52(37.1%) of all patients. Of 52 patients, 28 patients (53.8%) had positive findings of
H.pylori. There were no statistical differences in presence of H.pylori related with MSI
and P53.
Conclusions: Helicobacter pylori does not affect the expression of P53 and MSI in EGC
that are included in the indication of endoscopic resection.
P-0079 ECF / ECX / EOX FOR LOCAL ADVANCED OESOPHAGO-
GASTRIC CANCER - HISTOLOGICAL AND RADIOLOGICAL
RESPONSE ANALYSES
Christoph Treese1, Christoph Loddenkemper2, Martin Zeitz1, Jo¨rg Ritz3,
Severin Daum1
1Institute for Gastroenterology Charite´ Campus Benjamin Franlin, Berlin,
Germany, 2Institute for Pathology Charite´ Campus Benjamin Franlin, Berlin,
Germany, 3Institute for Surgery Charite Campus Benjamin Franlin, Berlin,
Germany
Introduction: The efficacy of ECF for the therapy of local advanced oesophago-gastric
cancer in terms of overall survival as well as disease-free survival has previously been
demonstrated (Cunningham et al, 2006). However, neither the histological nor the
radiological responses were analysed. The present study aimed at investigating these
parameters.
Method: Patients (N=22; mean age = 64 years (38-76)) with local advanced
oesophago-gastric cancer (gastro-esophageal junction: N = 14; stomach: N = 8) treated
with preoperative chemotherapy with ECF / ECX / EOX were evaluated for the period
2006-2009. The staging was standardized with endoscopic ultrasound, multislice
computed tomography before the initiation of chemotherapy and before surgery. The
radiological response was assessed according to RECIST and the histological response
in the resected specimen was assessed based on the criteria of Becker et al, 2003.
Results: The radiological analysis showed a response rate in 44% (14% complete and
40% partial response rates), a stable disease in 23% and a progressive disease in 45% of
cases. Furthermore, the histological analysis identified a grade I response in 18%,
a grade II response in 23% and a grade III response in 45% of cases. Concerning side
effects, 9% of the patients had adverse events grade III and 5% grade IV.
Conclusion: By showing response rates of 44% in the radiological and 31% in the
histological analysis the present study confirms that the preoperative therapy of local
advanced oesophago-gastric cancer with ECF / ECX / EOX is effective. In contrast to
imaging studies employing DCF (37% response (Van Cutsem et al, 2006) and
histological studies using PLF (36.7% response; Stahl et al), ECF/ECX/EOX had less
grade III-IV adverse events (DCF 69%, ECF/ECX/EOX 42%). Based on the present
findings the authors suggest that ECF / ECX / EOX treatment should be standard
therapy for primary operable local advanced oesophago-gastric cancer.
P-0080 HETEROGENEOUS EXPRESSION OF INTEGRINS IN PRIMARY
AND METASTATIC GASTRIC CANCER
Mareile Joka, Katharina Pietsch, Barbara Mayer, Karl-Walter Jauch
Surgery - University of Munich, Munich, Germany
Background: Metastatic spread of cancer cells is a key event in tumor progression and
in determining the prognosis of patients with malignant disease. Changes in expression
of adhesion molecules play a pivotal role in the induction of the tissue differentiation.
Our objectives were to correlate the expression pattern of various adhesion molecules
with the clinicopathological features and patient survival and confirm the results using
a coculture spheroid model.
Methods: The clinicopathological features of 94 patients (57,4% male, 42,6% female,
median age of 66,2 years) with gastric cancer were characterized using univariate and
multivariate analysis. Further we compared the expression profile of adhesion
molecules namely fibronectinreceptor, collagenreceptor, lamininreceptor,
vitronectinreceptor, E-Cadherin and VLA 4 in primary gastric tumors (n=94) and their
synchronous metastases (regional lymph nodes n=32, liver n=14, peritoneum n=17)
using Avidin Biotin complex immunoperoxidase staining. A coculture in vitro model,
i.e. the homo- and heterotypic spheroid model were performed as a functional test
system to confirm the microenvironmental impact on the biomarker expression level.
Results: Strong collagenreceptor expression was found in both primary and metastatic
tumors. High expression of collagenreceptor significantly correlated with metastatic
disease (UICC TNM stage IV, p=0,001). Contrary, the expression of lamininreceptor
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